Which are the causes of Sweet Syndrome?

TL;DR: Sweet Syndrome, also known as acute febrile neutrophilic dermatosis, is an inflammatory condition with an unknown primary cause, though it is widely believed to be a hypersensitivity reaction triggered by various underlying factors. It is not considered a hereditary genetic disease, but rather a reactive process often associated with infections, medications, or underlying malignancies.

What triggers Sweet Syndrome?

The exact etiology of Sweet Syndrome remains under investigation, but medical researchers categorize it into three primary forms: idiopathic (unknown cause), malignancy-associated, and drug-induced. Think of the immune system in Sweet Syndrome like a smoke alarm that goes off even when there is no fire; the body’s white blood cells (neutrophils) infiltrate the skin, causing painful, red plaques, often accompanied by fever.

Is Sweet Syndrome hereditary?

Sweet Syndrome is not considered a genetic or hereditary disorder, meaning it is not passed down through families via specific gene mutations. While researchers have studied potential genetic predispositions, there is no single chromosomal abnormality or gene linked to the development of Sweet Syndrome. Most cases are sporadic, meaning they occur in individuals without a family history.

What are the known risk factors for Sweet Syndrome?

While the cause is not fully understood, clinical data identifies several clear risk factors that can "trigger" an episode of Sweet Syndrome. These include:

• Infections: Upper respiratory infections or gastrointestinal issues often precede the onset.


• Medications: Certain drugs, such as granulocyte-colony stimulating factor (G-CSF) used in cancer treatment, are known to induce Sweet Syndrome.


• Malignancy: Approximately 15-20% of cases are associated with internal cancers, most commonly acute myeloid leukemia (AML).


• Autoimmune disorders: Conditions like inflammatory bowel disease or rheumatoid arthritis can sometimes coincide with the development of Sweet Syndrome.

What is the current focus of research?

Current research into Sweet Syndrome is focused on understanding the dysregulation of cytokines—the chemical messengers that tell the immune system to activate. By mapping how these proteins interact, scientists hope to develop targeted therapies that stop the recruitment of neutrophils to the skin without suppressing the entire immune system.

Next steps

• Consult a dermatologist or rheumatologist for a skin biopsy to confirm the diagnosis.


• Review your medication list with your physician to rule out drug-induced triggers.


• Connect with the 73 community members at DiseaseMaps.org to share experiences and coping strategies.

Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Sweet Syndrome.


• Orphanet: Acute febrile neutrophilic dermatosis.


• PubMed/NCBI: "Pathophysiology and management of Sweet syndrome."


• OMIM (Online Mendelian Inheritance in Man): Research database for rare conditions.